Valuation: Medios AG

Market Cap 278M 310M 254M 232M 437M 29.13B 451M 3.06B 1.22B 15.54B 1.16B 1.14B 49.06B P/E 2026 *
13.5x
P/E 2027 * 9.44x
Enterprise Value 374M 417M 342M 312M 588M 39.19B 606M 4.12B 1.64B 20.91B 1.56B 1.53B 66.01B EV / Sales 2026 *
0.17x
EV / Sales 2027 * 0.15x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day+0.53%
1 week+7.18%
Current month+7.18%
1 month+4.42%
3 months+3.09%
6 months-19.23%
Current year-21.69%
1 week 10.5
Extreme 10.5
11.94
1 month 10.02
Extreme 10.02
11.94
Current year 9.98
Extreme 9.98
17.44
1 year 9.98
Extreme 9.98
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 31/01/2026
Director of Finance/CFO 54 14/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 06/11/2014
Director/Board Member 65 13/09/2016
Director/Board Member 57 09/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
12/08/26 Buy

Chief Financial Officer

3,500 0.0137%
04/02/26 Sell

Chief Executive Officer

13,638 0.0535%
22/01/26 Buy

Executive/Senior Manager

4,000 0.0157%
Change 5-day change 1-year change 3-year change Capi.($)
+0.53%+7.18%-7.65%-28.68% 310M
-0.79%-4.48%+44.44%+127.49% 1,206B
+1.43%+1.11%+47.73%+82.08% 665B
+1.07%-1.21%+32.99%+106.31% 515B
-0.36%-3.25%+47.17%+64.58% 381B
-0.14%-1.87%+71.05%+40.63% 362B
-0.78%-0.52%+30.57%+57.98% 307B
-0.80%-0.21%+8.54%+35.56% 289B
+0.03%-1.20%+45.89%+68.76% 249B
-0.41%-2.22%+35.24%+105.68% 207B
Average -0.02%-0.67%+35.60%+66.04% 418.01B
Weighted average by Cap. -0.04%-1.96%+42.23%+88.37%

Financials

2026 *2027 *
Net sales 2.17B 2.42B 1.98B 1.81B 3.41B 227B 3.51B 23.88B 9.52B 121B 9.07B 8.88B 383B 2.25B 2.5B 2.05B 1.87B 3.53B 235B 3.64B 24.75B 9.87B 126B 9.4B 9.2B 397B
Net income 20.76M 23.15M 18.98M 17.32M 32.64M 2.18B 33.67M 229M 91.21M 1.16B 86.9M 85.03M 3.67B 29.51M 32.9M 26.97M 24.62M 46.38M 3.09B 47.84M 325M 130M 1.65B 123M 121M 5.21B
Net Debt 96M 107M 87.73M 80.09M 151M 10.06B 156M 1.06B 422M 5.37B 402M 393M 16.95B 56.62M 63.13M 51.74M 47.23M 88.99M 5.93B 91.8M 624M 249M 3.17B 237M 232M 10B
Projected Income Statement - Annual - Medios AG
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
989
Date Price Change Volume
06/11/26 €11.34 +0.53% 28,306
05/11/26 €11.28 -2.93% 53,913
04/11/26 €11.62 +1.93% 68,285
03/11/26 €11.40 +2.89% 52,012
02/11/26 €11.08 +4.73% 43,423
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Medios AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
11.34EUR
Average target price
20.25EUR
Spread / Average Target
+78.57%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Medios AG
  1. Stock Market
  2. Stocks
  3. ILM1 Stock